moxonidine has been researched along with nifedipine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Amann, K; Ganten, U; Gharehbaghi, H; Greber, D; Lange, B; Mall, G; Mattfeldt, T; Wiest, G | 1 |
| Greber, D; Irzyniec, T; Mall, G; Ritz, E | 1 |
| Amann, K; Gharenhbaghi, H; Greber, D; Mall, G; Mattfeldt, T; Wiest, G | 1 |
| Amann, K; Mall, G; Nichols, C; Ritz, E; Schwarz, U; Tornig, J; Zeier, M | 1 |
| Amann, K; Mall, G; Nichols, C; Ritz, E; Törnig, J; Zeier, M | 1 |
| Robles, NR | 1 |
| Grishin, OV; Ruksin, VV | 1 |
| Chiritso, MM; Grishin, OV; Ruksin, VV | 1 |
12 other study(ies) available for moxonidine and nifedipine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats. Stereological studies on myocytes, capillaries, arteries, and cardiac interstitium.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Capillaries; Coronary Circulation; Heart; Hypertension; Imidazoles; Male; Myocardium; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1992 |
Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study.
Topics: Animals; Antihypertensive Agents; Blood Vessels; Glomerulosclerosis, Focal Segmental; Imidazoles; Kidney; Male; Nifedipine; Rats; Rats, Inbred SHR; Renal Circulation | 1992 |
Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR)--stereological studies on myocytes, capillaries, arteries, and cardiac interstitium.
Topics: Animals; Blood Pressure; Drug Evaluation, Preclinical; Heart; Hypertension; Imidazoles; Male; Myocardium; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1991 |
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
Topics: Animals; Antihypertensive Agents; Capillaries; Imidazoles; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Nifedipine; Ramipril; Rats; Rats, Sprague-Dawley; Renal Circulation | 1996 |
Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Arterioles; Calcium Channel Blockers; Capillaries; Coronary Disease; Coronary Vessels; Endomyocardial Fibrosis; Hemodynamics; Imidazoles; Kidney Failure, Chronic; Male; Nephrectomy; Nifedipine; Ramipril; Rats; Rats, Sprague-Dawley; Sympatholytics; Vasodilator Agents | 1996 |
[New central agents in the treatment of arterial hypertension].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Adult; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Clonidine; Diabetes Complications; Humans; Hypertension; Imidazoles; Nifedipine; Oxazoles; Renin-Angiotensin System; Reserpine; Rilmenidine; Risk Factors; Sympathetic Nervous System; Vasodilator Agents | 1999 |
[Acute management at the rising of arterial pressure which is not menacing to a life].
Topics: Acute Disease; Adrenergic alpha-2 Receptor Agonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Captopril; Clonidine; Electrocardiography; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Nifedipine; Severity of Illness Index; Sympatholytics; Treatment Outcome | 2011 |
[The efficacy of antihypertension drugs and their combinations in the non-treated hypertension].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Nifedipine; Treatment Outcome | 2013 |